The 42% bump in Oxford Nanopore Technologies’ shares on its first day on the London exchange means that the company’s valuation is now further divorced from its sales figures than ever before. Its market cap sits at around £4.8bn ($6.5bn), despite sales coming in at just £59m in the first half of this year.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,